Meitheal Product Catalog
Customer Service Information
Report an Adverse Drug Event
Return Goods Policy
Anti-Capital Punishment Statement
Meitheal Pharmaceuticals has Bortezomib for Injection Now Available.
Jul 26 2022
Pharmaceuticals Earns Great Place to Work Certification™ and Is Named One of Best Places to Work in Illinois
Jul 19 2022
Meitheal Pharmaceuticals has Decitabine for Injection Now Available.
Jul 11 2022
Meitheal Pharmaceuticals has Pemetrexed for Injection, USP Now Available.
May 25 2022
Meitheal Pharmaceuticals Announces Membership in The Association for Accessible Medicines
May 02 2022
Meitheal Pharmaceuticals is pleased to announce that Haloperidol Decanoate Injection is Now Available.
Apr 12 2022
Meitheal Pharmaceuticals has Succinylcholine Chloride Injection, USP Now Available.
Mar 30 2022
Meitheal Pharmaceuticals Announces Findings from Collaborative Research Study with Premier Inc. Evaluating Anticoagulant Treatment of COVID-19 Patients
Sep 15 2021
Customer Notification Recall Communication Letter
Urgent: Glycopyrrolate Injection, USP 4mg per 20mL RECALL
Sep 03 2021
NKF and Meitheal Announce Dr. Jiali Luo as General Manager of New Biopharmaceutical Business
May 20 2021
Meitheal Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Cisatracurium Besylate Injection, USP 10mg per 5mL Due to Mislabeling
Jan 28 2021